Kate Dellorusso
Stock Analyst at LifeSci Capital
(2.45)
# 3,078
Out of 4,707 analysts
20
Total ratings
52.9%
Success rate
4.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UPB Upstream Bio | Maintained: Buy | $19 | $6.19 | +206.95% | 14 | Sep 1, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.2546 | - | 4 | Aug 15, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $13 | $6.06 | +114.52% | 2 | Aug 6, 2026 |
Upstream Bio
Sep 1, 2026
Maintained: Buy
Price Target: $19
Current: $6.19
Upside: +206.95%
Mereo BioPharma Group
Aug 15, 2026
Maintained: Hold
Price Target: n/a
Current: $0.2546
Upside: -
Aclaris Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $13
Current: $6.06
Upside: +114.52%